151 related articles for article (PubMed ID: 12106771)
1. Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.
Govitrapong P; Mukda S; Turakitwanakan W; Dumrongphol H; Chindaduangratn C; Sanvarinda Y
Neurochem Int; 2002 Oct; 41(4):209-16. PubMed ID: 12106771
[TBL] [Abstract][Full Text] [Related]
2. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
Govitrapong P; Chagkutip J; Turakitwanakan W; Srikiatkhachorn A
Psychiatry Res; 2000 Sep; 96(1):41-50. PubMed ID: 10980325
[TBL] [Abstract][Full Text] [Related]
3. Platelet serotonin transporter.
Rudnick G; Humphreys CJ
Methods Enzymol; 1992; 215():213-24. PubMed ID: 1435323
[No Abstract] [Full Text] [Related]
4. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of neuroleptics at human monoamine transporters.
Tatsumi M; Jansen K; Blakely RD; Richelson E
Eur J Pharmacol; 1999 Mar; 368(2-3):277-83. PubMed ID: 10193665
[TBL] [Abstract][Full Text] [Related]
7. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals.
Barkan T; Peled A; Modai I; Weizman A; Rehavi M
Eur Neuropsychopharmacol; 2006 Aug; 16(6):429-36. PubMed ID: 16431091
[TBL] [Abstract][Full Text] [Related]
9. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron.
Bellini M; Rappelli L; Blandizzi C; Costa F; Stasi C; Colucci R; Giannaccini G; Marazziti D; Betti L; Baroni S; Mumolo MG; Marchi S; Del Tacca M
Am J Gastroenterol; 2003 Dec; 98(12):2705-11. PubMed ID: 14687821
[TBL] [Abstract][Full Text] [Related]
10. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies.
Pandey GN
Ann N Y Acad Sci; 1997 Dec; 836():182-200. PubMed ID: 9616799
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Markianos M; Hatzimanolis J; Lykouras L
Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term lithium treatment on monoaminergic functions in major depression.
El Khoury A; Johnson L; Aberg-Wistedt A; Stain-Malmgren R
Psychiatry Res; 2001 Dec; 105(1-2):33-44. PubMed ID: 11740973
[TBL] [Abstract][Full Text] [Related]
13. Platelet serotonin transporter density and related parameters in endurance-trained and sedentary male subjects.
Strachan AT; Maughan RJ
Acta Physiol Scand; 1998 Jun; 163(2):165-71. PubMed ID: 9648635
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonin concentrations in medicated schizophrenic patients.
Kaneda Y; Fujii A; Nagamine I
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jul; 25(5):983-92. PubMed ID: 11444685
[TBL] [Abstract][Full Text] [Related]
15. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics.
Malhotra AK; Goldman D; Mazzanti C; Clifton A; Breier A; Pickar D
Mol Psychiatry; 1998 Jul; 3(4):328-32. PubMed ID: 9702741
[TBL] [Abstract][Full Text] [Related]
16. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
[TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients.
Barkan T; Peled A; Modai I; Barak P; Weizman A; Rehavi M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):572-9. PubMed ID: 16713194
[TBL] [Abstract][Full Text] [Related]
18. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
[TBL] [Abstract][Full Text] [Related]
19. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
Lingjaerde O
Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
[TBL] [Abstract][Full Text] [Related]
20. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.
Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT
Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
